Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia, Blood Rev, vol.24, pp.135-141, 2010. ,
Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?, Leuk Lymphoma, vol.54, pp.2351-2364, 2013. ,
Prognostic markers in chronic lymphocytic leukemia: a comprehensive review, Blood Rev, vol.23, pp.25-47, 2009. ,
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation, J Exp Med, vol.208, pp.1389-1401, 2011. ,
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness, Blood, vol.118, pp.6904-6908, 2011. ,
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia, Blood, vol.119, pp.2854-2862, 2012. ,
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia, Blood, vol.121, pp.1403-1412, 2013. ,
SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients, Leukemia, vol.28, pp.108-117, 2013. ,
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia, Cell, vol.152, pp.714-726, 2013. ,
Waldenströ m's macroglobulinaemia: an indolent B-cell lymphoma with distinct molecular and clinical features, Hematol Oncol, vol.31, issue.1, pp.76-80, 2013. ,
Temporal and geographic variations of Waldenstrom macroglobulinemia incidence: a large population-based study, Cancer, vol.118, pp.3793-3800, 2012. ,
A new era for Waldenstrom macroglobulinemia: MYD88 L265P, Blood, vol.121, pp.4434-4436, 2013. ,
IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenströ m macroglobulinemia/lymphoplasmacytic lymphomas, Leukemia, vol.27, pp.183-189, 2013. ,
Differential diagnosis of Waldenstrom's macroglobulinemia and other B-cell disorders, Clin Lymphoma, vol.5, pp.235-240, 2005. ,
Prevalence, clinical aspects, and natural history of IgM MGUS, Cytometry B Clin Cytom, vol.78, issue.1, pp.91-97, 2010. ,
Long-term follow-up of IgM monoclonal gammopathy of undetermined significance, Blood, vol.102, pp.3759-3764, 2003. ,
Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma, Blood, vol.108, pp.2755-2763, 2006. ,
Gene expression profiling of B lymphocytes and plasma cells from Waldenströ m's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals, Leukemia, vol.21, pp.541-549, 2007. ,
IgG-Switched CLL has a distinct immunogenetic signature from the common MD Variant: ontogenetic implications, Clin Cancer Res Off J Am Assoc Cancer Res, vol.20, pp.323-330, 2014. ,
Prognostic significance of serum immunoglobulin paraprotein in patients with chronic lymphocytic leukemia, Leuk Res, vol.35, pp.1060-1065, 2011. ,
Correlation of chromosome abnormalities with laboratory features and clinical course in B-cell chronic lymphocytic leukaemia, Br J Haematol, vol.76, pp.352-358, 1990. ,
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936, Leukemia, vol.17, pp.2257-2317, 2003. ,
Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas, Proc Natl Acad Sci, vol.97, pp.10209-10213, 2000. ,
Genomic aberrations and survival in chronic lymphocytic leukemia, N Engl J Med, vol.343, pp.1910-1916, 2000. ,
Comparison of a quantitative PCR method with FISH for the assessment of the four aneuploidies commonly evaluated in CLL patients, Leukemia, vol.21, pp.1460-1463, 2007. ,
Very low levels of surface CD45 reflect CLL cell fragility, are inversely correlated with trisomy 12 and are associated with increased treatment-free survival, Am J Hematol, vol.88, pp.747-753, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00903796
B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL, Blood, vol.78, pp.1901-1914, 1991. ,
Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia, Blood, vol.94, pp.1848-1854, 1999. ,
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia, Blood, vol.94, pp.1840-1847, 1999. ,
Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method, Haematologica, vol.93, pp.215-223, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00451240
Is ) leukemia * an appropriate label for all patients who meet the diagnostic criteria of chronic lymphocytic leukemia?, Leuk Res, vol.31, pp.273-275, 2007. ,
White blood cell count at diagnosis and immunoglobulin variable region gene mutations are independent predictors of treatment-free survival in young patients with stage A chronic lymphocytic leukemia, Haematologica, vol.96, pp.626-630, 2011. ,
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies, Blood, vol.119, pp.4467-4475, 2012. ,
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2, Leukemia, vol.27, pp.2196-2199, 2013. ,
Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients, Am J Clin Pathol, vol.123, pp.200-205, 2005. ,
MYD88 L265P in Waldenströ m macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allelespecific polymerase chain reaction, Blood, vol.121, pp.2051-2058, 2013. ,
MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenströ m's macroglobulinemia, Leukemia, vol.27, pp.1722-1728, 2013. ,
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia, Br J Haematol, vol.144, pp.217-222, 2009. ,
Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia, Cancer Sci, vol.100, pp.2346-2353, 2009. ,
Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome, Br J Haematol, vol.142, pp.202-215, 2008. ,
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia, Blood, vol.121, pp.4902-4905, 2013. ,
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma, Haematologica, vol.95, pp.1792-1796, 2010. ,
Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly-and self-reactive antibodies with similar reactivity, Blood, vol.118, pp.3331-3339, 2011. ,
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications, Leukemia, vol.26, pp.1638-1646, 2012. ,
On the way towards a ) CLL prognostic index *: focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort, Leukemia, vol.28, pp.710-713, 2013. ,
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia, Nature, vol.475, pp.101-105, 2011. ,
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation, Br J Haematol, vol.146, pp.689-691, 2009. ,
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL, Br J Haematol, vol.151, pp.404-406, 2010. ,
SF3B1 and other novel cancer genes in chronic lymphocytic leukemia, N Engl J Med, vol.365, pp.2497-2506, 2011. ,
NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome, Leukemia, vol.27, pp.1100-1106, 2013. ,
NOTCH1 mutations in CLL associated with trisomy 12, Blood, vol.119, pp.329-331, 2012. ,
Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia, Blood, vol.118, pp.2821-2826, 2011. ,
Long survival in B-CLL correlates with surface IgM kappa phenotype, Br J Haematol, vol.66, pp.21-26, 1987. ,
Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein, Am J Clin Pathol, vol.123, pp.594-602, 2005. ,
Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study Group, Eur J Haematol, vol.93, pp.29-33, 2014. ,
Viñ olas N. Serum immunoglobulins in B-chronic lymphocytic leukemia. Natural history and prognostic significance, Cancer, vol.61, pp.279-283, 1988. ,
Prognosis of Binet stage A chronic lymphocytic leukemia patients: the strength of routine parameters, Blood, vol.116, pp.4588-4590, 2010. ,
Gene expression profiling in chronic lymphocytic leukaemia, Best Pract Res Clin Haematol, vol.22, pp.211-222, 2009. ,
Chronic lymphocytic leukaemia--the role of the microenvironment pathogenesis and therapy, Br J Haematol, vol.162, pp.15-24, 2013. ,
, ) IgM or IgG peaks in CLL are associated with short TFS D Rizzo et al